Report Highlights
The global molecular, atomic and nanoscale imaging market was nearly $3.1 billion in 2011 and nearly $3.2 billion in 2012. This market is expected to grow to $4.4 billion by 2017, a compound annual growth rate (CAGR) of 6.8% from 2012 to 2017.
Report Includes
- An overview of the global market for molecular, nanoscale, and atomic imaging.
- Analyses of global market trends, with data from 2010 through 2012, and projections of compound annual growth rates (CAGRs) through 2017.
- Descriptions of imaging equipment and technologies for examining materials, electronics, and biological samples.
- Coverage of technological issues, including novel molecular, nanometer, and atomic imaging capabilities.
- Examination of research activities and areas of interest related to imaging applications.
- Comprehensive company profiles of major players.
SCOPE OF THE STUDY
The scope of this study encompasses the global markets and technologies of the molecular, nanoscale and atomic imaging markets in pharmaceutical and biotechnology markets. BCC analyzes each market and its applications, regulatory environment, technology involved, market projections and market share. Technological issues include the latest trends and developments. The emerging market for molecular, nanoscale and atomic imaging includes countries such as India, China, Japan, Korea, Taiwan, Africa, Australia and New Zealand.
Analyst Credentials
Shalini Shahani Dewan focuses on pharmaceuticals and biotechnology and has been a BCC Research contributor since 2002 as both an analyst and project manager. She has explored a wide range of topics and companies, including working for Johnson & Johnson doing market surveillance. She has an undergraduate degree in pharmacy and master's degree in medicinal chemistry. She resides in the Bay Area.
Report Highlights
-
The U.S. market for molecular, nanoscale, and atomic imaging is valued at $1.8 billion in 2007 and is expected to have a compound annual growth rate (CAGR) of 18.5%, reaching $4.2 billion in 2012.
-
Imaging hardware systems represent 69.7% of the total molecular, nanoscale, and atomic imaging market with a value of $1.3 billion in 2007. This segment is expected to grow with a compound annual growth rate of 18% to exceed $2.8 billion in 2012.
-
Within the imaging systems market, the scanning electron microscopes segment is expected to be worth $601.3 million by 2012.
Related Reports
Global Markets for Medical Imaging Reagents and Analysis Equipment
The global medical imaging market was valued at $25.4 billion in 2011 and should reach $26.7 billion in 2012. Total market value is expected to reach nearly $34.1 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 5%.
Biologic Imaging Reagents: Technologies and Global Markets
The global market for biologic imaging reagents was valued at $9.4 billion in 2011 and is expected to reach $9.9 billion in 2012. Total market value is expected to reach nearly $14.5 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 7.8%.
Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets
The global pharmaceutical contract manufacturing and contract research organizations revenue reached $196.5 billion in 2010, and it will further grow to $217.9 billion in 2011. The market is projected to reach $360.6 billion by 2016, increasing at a compound annual growth rate (CAGR) of 10.6%.
Medical Imaging Technologies for Oncology Diagnostics: The Global Market
The global market for diagnostic imaging equipment for oncology reached more than $11.6 billion in 2010 and, despite the global recession, is forecast to grow to about $14.8 billion by 2015, an overall compound annual growth rate (CAGR) of 5% for 2010 through 2015.
Recent Reports
Global Markets and Technologies for Nanofiltration
The global market for nanofiltration is expected to grow from $1.5 billion in 2024 and is projected to reach $3.4 billion by the end of 2029, at a compound annual growth rate (CAGR) of 17.6% during the forecast period of 2024 to 2029.
Global Markets and Technologies for Carbon Nanotubes
The global market for carbon nanotubes was valued at $2.0 billion in 2023. The market is projected to grow from $2.3 billion in 2024 to $5.9 billion by 2029, at a compound annual growth rate (CAGR) of 20.6% from 2024 through 2029.
Global Markets and Technologies for Nanofibers
The global market for nanofibers is estimated to increase from $2.9 billion in 2023 to reach $9.4 billion by 2028, at a compound annual growth rate (CAGR) of 26.0% from 2023 through 2028.
Global Nanotechnology Market
The global market for nanotechnology is estimated to increase from $68.0 billion in 2023 to reach $183.7 billion by 2028, at a compound annual growth rate (CAGR) of 22.0% from 2023 through 2028.
Nanotechnology in Energy Applications
The global nanotechnology in energy applications market should reach $18.8 billion by 2028 from $9.3 billion in 2023 at a compound annual growth rate (CAGR) of 15.0% for the forecast period of 2023 to 2028.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More